Skip to main content
. 2019 Jul 4;11(7):315. doi: 10.3390/pharmaceutics11070315

Figure 4.

Figure 4

Effect of PCL type on daily release rates of TAF (mg/day) from implants with different wall thicknesses and fabricated with (■) Sigma -PCL or (○) PC-12. Implants contained a formulation of 2:1 TAF-castor Oil. Daily release rates were calculated from release over at 35 days and three implants were tested per condition.